Tilman Brummer
- Oncology top 2%
- Peptidase Inhibition and Analysis 7
- Immunology top 5%
- Molecular Biology top 2%
- Melanoma and MAPK Pathways 25
- Protein Tyrosine Phosphatases 14
- Ubiquitin and proteasome pathways 13
- Protein Kinase Regulation and GTPase Signaling 11
- PI3K/AKT/mTOR signaling in cancer 8
- Cancer Research top 5%
- Cell Biology top 2%
-
- Cancer Mechanisms and Therapy 9
-
- Chronic Lymphocytic Leukemia Research 8
- Co-authors
- Roger J. DalyPhilippa M. O’BrienKate PattersonMichael RethRobert ZeiserRicarda HerrShaima’a HamarshehOlaf Groß
- Cited by
- OncologyImmunologyMolecular Biology
- Partner nations
- GermanyAustraliaUnited States
In The Last Decade
Tilman Brummer
93 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.2k
- Immunology 897
- Molecular Biology 2.9k
- Cancer Research 547
- Cell Biology 468
Countries citing papers authored by Tilman Brummer
This map shows the geographic impact of Tilman Brummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Brummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Brummer more than expected).
Fields of papers citing papers by Tilman Brummer
This network shows the impact of papers produced by Tilman Brummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Brummer. The network helps show where Tilman Brummer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tilman Brummer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2022 | 22 | |
| 4 | 2022 | 81 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 8 | |
| 7 | 2020 | 22 | |
| 8 | 2020 | 46 | |
| 9 | 2020 | 232 | |
| 10 | 2019 | 11 | |
| 11 | 2018 | 34 | |
| 12 | 2017 | 47 | |
| 13 | 2017 | 85 | |
| 14 | 2016 | 64 | |
| 15 | 2015 | 26 | |
| 16 | 2014 | 42 | |
| 17 | 2014 | 28 | |
| 18 | 2012 | 33 | |
| 19 | 2012 | 42 | |
| 20 | Dual-specificity phosphatases: critical regulators with diverse cellular targetsbreakdown → | 2009 | 580 |
About Tilman Brummer
Tilman Brummer is a scholar working on Genetics, Oncology, Immunology, Molecular Biology and Hematology, having authored 98 papers that have together received 4.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (25 papers), Protein Tyrosine Phosphatases (14 papers), Ubiquitin and proteasome pathways (13 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Cancer Mechanisms and Therapy (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (897 citations), Molecular Biology (2.9k citations), Cancer Research (547 citations) and Cell Biology (468 citations). Tilman Brummer has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Roger J. Daly, Philippa M. O’Brien, Kate Patterson, Michael Reth, Robert Zeiser, Ricarda Herr, Shaima’a Hamarsheh, Olaf Groß, Michael Röring and Hassan Jumaa. Their work appears in journals such as Cell Communication and Signaling, Oncogene, Oncotarget, The EMBO Journal and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.